Endo International (ENDP) said Monday it has agreed to pay $8.05 billion to private equity firm TPG to buy Par Pharmaceutical Holdings, a deal aimed at expanding its growing generics business.
The stock-and-cash deal, approved by the boards of both companies, will create one of "the top five" generics manufacturers in terms of U.S. sales, Endo said.
20:05 Headphone deal of the day: Klipsch Reference On-Ear Premium headphone for $30
11:32 Brexit: EU negotiator says 'time's short' for reaching deal11
09:13 Rouhani says Iran will not let Trump rip up nuclear deal13
07:14 Italy Votes in Referendum With PM Matteo Renzi's Future at Stake14